Official ESCRS | European Society of Cataract & Refractive Surgeons
Lisbon 2017 Delegate Registration Programme Exhibition Virtual Exhibition Satellites OneWorld Travel Discount
escrs app advert

The prevalence of age-related eye diseases and cataract surgery among older adults in the city of Lodz, Poland

Search Title by author or title

Session Details

Session Title: Endophthalmitis/ Ocular Infections/ Miscellaneous

Session Date/Time: Tuesday 10/10/2017 | 08:00-10:30

Paper Time: 09:20

Venue: Room 4.6

First Author: : M.Nowak POLAND

Co Author(s): :    J. Smigielski   P. Jurowski                 

Abstract Details

Purpose:

To determine the prevalence of age-related eye diseases and cataract surgery among older adults in the city of Lodz, in central Poland.

Setting:

Medical University of Lodz, Department of Ophthalmology and Visual Rehabilitation, 113 Zeromskiego str., Lodz 90-549, Poland

Methods:

The study design was cross-sectional and observational study. A total of 1107 women and men of predominantly Caucasian origin were successfully enumerated and recruited for the study. All selected subjects were interviewed and underwent detailed ophthalmic examinations.

Results:

Overall 8.04% (95% CI 6.44-9.64) subjects had cataract surgery in either eye. After excluding subjects with bilateral cataract surgery, the prevalence of cataract was 12.10% (95% CI 10.18-14.03). AMD was found in 4.33% (95% CI 3.14-5.54 ) of all subjects. Of them 3.25% (95% CI 2.21-4.30 ) had early AMD and 1.08% (95% CI 0.47-1.69) had late AMD. Various types of glaucoma were diagnosed in 5.51% (95% CI 4.17-6.85) of subjects and 2.62% (95% CI 1.68-3.56) had OHT. The prevalence rates of DR and myopic macular degeneration were 1.72% (95% CI 0.95-2.48) and 0.45% (95% CI 0.06-0.85) respectively.

Conclusions:

The study revealed high prevalence of age-related eye diseases in this older population. All multiple logistic regression models were only significantly associated with older age. The highest rate of visual impairment was observed among subjects with retinal diseases.

Financial Disclosure:

NONE

Back to previous